Isifinyezo | Ukutholwa kwe-antibody eyenza i-neutralize ngokumelene ne-bursa ethelelanayo ye-Fabricius virus ku-serum yenkukhu |
Okuhloswe ngakho Ukuthola | I-anti-virus ye-bursal virus yenkukhu |
Isampula | I-Serum
|
Ubuningi | 1 kit = 192 Test |
Ukuzinza kanye Nesitoreji | 1) Wonke ama-reagents kufanele agcinwe ku-2 ~ 8℃.Ungaqandi. 2) Impilo yeshelufu yizinyanga eziyi-12.Sebenzisa wonke ama-reagents ngaphambi kosuku lokuphelelwa yisikhathi kukhithi.
|
Isifo se-bursal esithathelwanayo(IBD), eyaziwa nangokuthi isifo seGumboro, i-infectious bursitis kanye ne-infectious avian nephrosis, isifo esithathelwanayo kakhulu entsheni.izinkukhukanye nama-turkeys abangelwa igciwane le-infectious bursal disease (IBDV), elibonakala ngokuthiimmunosuppressionkanye nokufa ngokuvamile emavikini angu-3 kuya kwangu-6 ubudala.Lesi sifo satholwa okokuqala ngoGumboro, DelawareNgo-1962. Kubaluleke kakhulu kwezomnotho embonini yezinkukhu emhlabeni wonke ngenxa yokwanda kokungenwa ezinye izifo kanye nokuphazamiseka okungekuhle kokusebenza ngempumelelo.ukugoma.Eminyakeni yamuva nje, kuye kwavela izinhlobo ezinonya kakhulu ze-IBDV (vvIBDV), ezibangela ukufa okukhulu kwenkukhu, eYurophu,i-Latin America,I-South-East Asia, Afrika kanyeEmaphakathi Mpumalanga.Ukutheleleka kungena emzileni we-oro-fecal, lapho inyoni ethintekile ikhipha amazinga aphezulu egciwane cishe amasonto amabili ngemuva kokutheleleka.Lesi sifo sisakazeka kalula sisuka ezinkukhwini ezinegciwane siye ezinkukhwini ezinempilo ngokudla, amanzi, nangokuthintana ngokomzimba.
Ikhithi isebenzisa indlela ye-ELISA yokuncintisana, iphrotheni ye-VP2 yegciwane le-bursal efakwe ngaphambilini ku-microplate, futhi iqhudelane ne-anti-VP2 protein antibody ku-serum ye-vector yesigaba esiqinile kusetshenziswa i-anti-VP2 protein monoclonal antibody.Ekuhlolweni, i-monoclonal antibody ezohlolwa kanye ne-anti-VP2 protein yengezwe, futhi ngemva kokufukamela, uma isampula iqukethe igciwane le-bursal disease elithathelwanayo lenkukhu i-VP2 protein-specific antibody, libophezela ku-antigen epuleti elimboziwe.Ngaleyo ndlela kuvimbela ukuboshwa kwe-anti-VP2 protein monoclonal antibody ku-antigen, ngemva kokugeza ukuze kukhishwe i-antibody engaboshiwe nezinye izakhi;bese wengeza i-enzyme emele igundane enelebula i-antibody yesibili ukuze ibophezele ngokukhethekile ku-antigen-antibody complex epuleti lokubona;I-conjugate ye-enzyme engaboshiwe isuswa ngokugeza;i-substrate ye-TMB yengezwa ku-microwell ukuze kuthuthukiswe umbala, futhi inani lokumunca lesampula lihlotshaniswa kabi nokuqukethwe kwe-anti-VP2 protein antibody equkethwe kuyo, ngaleyo ndlela kufezwe injongo yokuthola i-anti-VP2 protein antibody kusampula.
I-Reagent | Ivolumu 96 Izivivinyo/192Izivivinyo | ||
1 |
| 1e/2e | |
2 |
| 2.0ml | |
3 |
| 1.6ml | |
4 |
| 100ml | |
5 |
| 100ml | |
6 |
| 11/22ml | |
7 |
| 11/22ml | |
8 |
| 15ml | |
9 |
| 2 eya/4 | |
10 | i-serum dilution microplate | 1e/2e | |
11 | Isiyalezo | 1 ama-pcs |